vs
Ameren（AEE）与Ventas（VTR）财务数据对比。点击上方公司名可切换其他公司
Ameren的季度营收约是Ventas的1.1倍（$1.8B vs $1.7B），Ameren净利率更高（14.2% vs 3.6%，领先10.6%），Ventas同比增速更快（22.0% vs -8.2%），过去两年Ventas的营收复合增速更高（17.5% vs -0.9%）
Ameren Corporation是美国公共事业控股企业，下设Ameren密苏里、伊利诺伊州配电、伊利诺伊州天然气、输电四大业务板块，主营受费率监管的发电、输电、配电业务，以及受监管的天然气输配业务，电力生产主要采用煤炭、核电等能源。
Ventas是一家领先的医疗地产投资信托企业，旗下资产涵盖养老社区、医疗办公楼、生命科学研究设施及康复医疗中心等，主要在北美、英国地区运营，为医疗服务及生命科学机构提供专业物业解决方案。
AEE vs VTR — 直观对比
营收规模更大
AEE
是对方的1.1倍
$1.7B
营收增速更快
VTR
高出30.2%
-8.2%
净利率更高
AEE
高出10.6%
3.6%
两年增速更快
VTR
近两年复合增速
-0.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.8B | $1.7B |
| 净利润 | $253.0M | $59.0M |
| 毛利率 | — | — |
| 营业利润率 | 20.2% | — |
| 净利率 | 14.2% | 3.6% |
| 营收同比 | -8.2% | 22.0% |
| 净利润同比 | 21.6% | 19.0% |
| 每股收益（稀释后） | $0.92 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AEEVTR
| Q1 26 | — | $1.7B | ||
| Q4 25 | $1.8B | $1.6B | ||
| Q3 25 | $2.7B | $1.5B | ||
| Q2 25 | $2.2B | $1.4B | ||
| Q1 25 | $2.1B | $1.4B | ||
| Q4 24 | $1.9B | $1.3B | ||
| Q3 24 | $2.2B | $1.2B | ||
| Q2 24 | $1.7B | $1.2B |
净利润AEEVTR
| Q1 26 | — | $59.0M | ||
| Q4 25 | $253.0M | $73.0M | ||
| Q3 25 | $641.0M | $68.7M | ||
| Q2 25 | $277.0M | $71.5M | ||
| Q1 25 | $290.0M | $48.4M | ||
| Q4 24 | $208.0M | $58.7M | ||
| Q3 24 | $457.0M | $21.0M | ||
| Q2 24 | $260.0M | $21.2M |
营业利润率AEEVTR
| Q1 26 | — | — | ||
| Q4 25 | 20.2% | 4.9% | ||
| Q3 25 | 30.6% | 3.0% | ||
| Q2 25 | 18.5% | 3.0% | ||
| Q1 25 | 20.5% | 3.0% | ||
| Q4 24 | 10.2% | -0.0% | ||
| Q3 24 | 27.0% | 1.5% | ||
| Q2 24 | 21.3% | -1.6% |
净利率AEEVTR
| Q1 26 | — | 3.6% | ||
| Q4 25 | 14.2% | 4.7% | ||
| Q3 25 | 23.7% | 4.6% | ||
| Q2 25 | 12.5% | 5.0% | ||
| Q1 25 | 13.8% | 3.6% | ||
| Q4 24 | 10.7% | 4.6% | ||
| Q3 24 | 21.0% | 1.7% | ||
| Q2 24 | 15.4% | 1.8% |
每股收益（稀释后）AEEVTR
| Q1 26 | — | — | ||
| Q4 25 | $0.92 | $0.15 | ||
| Q3 25 | $2.35 | $0.14 | ||
| Q2 25 | $1.01 | $0.15 | ||
| Q1 25 | $1.07 | $0.10 | ||
| Q4 24 | $0.77 | $0.13 | ||
| Q3 24 | $1.70 | $0.05 | ||
| Q2 24 | $0.97 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $13.0M | $183.6M |
| 总债务越低越好 | $19.4B | — |
| 股东权益账面价值 | $13.4B | $13.2B |
| 总资产 | $48.5B | $27.7B |
| 负债/权益比越低杠杆越低 | 1.45× | — |
8季度趋势，按日历期对齐
现金及短期投资AEEVTR
| Q1 26 | — | $183.6M | ||
| Q4 25 | $13.0M | $741.1M | ||
| Q3 25 | $9.0M | $188.6M | ||
| Q2 25 | $11.0M | $614.2M | ||
| Q1 25 | $23.0M | $182.3M | ||
| Q4 24 | $7.0M | $897.9M | ||
| Q3 24 | $17.0M | $1.1B | ||
| Q2 24 | $19.0M | $557.1M |
总债务AEEVTR
| Q1 26 | — | — | ||
| Q4 25 | $19.4B | $13.0B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $17.8B | $13.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益AEEVTR
| Q1 26 | — | $13.2B | ||
| Q4 25 | $13.4B | $12.5B | ||
| Q3 25 | $12.8B | $12.4B | ||
| Q2 25 | $12.3B | $11.5B | ||
| Q1 25 | $12.2B | $11.5B | ||
| Q4 24 | $12.1B | $10.8B | ||
| Q3 24 | $11.8B | $9.8B | ||
| Q2 24 | $11.5B | $9.6B |
总资产AEEVTR
| Q1 26 | — | $27.7B | ||
| Q4 25 | $48.5B | $27.6B | ||
| Q3 25 | $47.4B | $26.9B | ||
| Q2 25 | $46.6B | $26.5B | ||
| Q1 25 | $45.7B | $26.0B | ||
| Q4 24 | $44.6B | $26.2B | ||
| Q3 24 | $43.3B | $25.3B | ||
| Q2 24 | $42.3B | $24.5B |
负债/权益比AEEVTR
| Q1 26 | — | — | ||
| Q4 25 | 1.45× | 1.04× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.47× | 1.26× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $956.0M | — |
| 自由现金流经营现金流 - 资本支出 | $-54.0M | — |
| 自由现金流率自由现金流/营收 | -3.0% | — |
| 资本支出强度资本支出/营收 | 56.7% | — |
| 现金转化率经营现金流/净利润 | 3.78× | — |
| 过去12个月自由现金流最近4个季度 | $-775.0M | — |
8季度趋势，按日历期对齐
经营现金流AEEVTR
| Q1 26 | — | — | ||
| Q4 25 | $956.0M | $471.7M | ||
| Q3 25 | $1.1B | $378.6M | ||
| Q2 25 | $862.0M | $475.3M | ||
| Q1 25 | $431.0M | $321.1M | ||
| Q4 24 | $817.0M | $373.6M | ||
| Q3 24 | $897.0M | $353.7M | ||
| Q2 24 | $557.0M | $335.9M |
自由现金流AEEVTR
| Q1 26 | — | — | ||
| Q4 25 | $-54.0M | — | ||
| Q3 25 | $116.0M | — | ||
| Q2 25 | $-204.0M | — | ||
| Q1 25 | $-633.0M | — | ||
| Q4 24 | $-473.0M | — | ||
| Q3 24 | $-240.0M | — | ||
| Q2 24 | $-445.0M | — |
自由现金流率AEEVTR
| Q1 26 | — | — | ||
| Q4 25 | -3.0% | — | ||
| Q3 25 | 4.3% | — | ||
| Q2 25 | -9.2% | — | ||
| Q1 25 | -30.2% | — | ||
| Q4 24 | -24.4% | — | ||
| Q3 24 | -11.0% | — | ||
| Q2 24 | -26.3% | — |
资本支出强度AEEVTR
| Q1 26 | — | — | ||
| Q4 25 | 56.7% | — | ||
| Q3 25 | 36.6% | — | ||
| Q2 25 | 48.0% | — | ||
| Q1 25 | 50.7% | — | ||
| Q4 24 | 66.5% | — | ||
| Q3 24 | 52.3% | — | ||
| Q2 24 | 59.2% | — |
现金转化率AEEVTR
| Q1 26 | — | — | ||
| Q4 25 | 3.78× | 6.46× | ||
| Q3 25 | 1.72× | 5.51× | ||
| Q2 25 | 3.11× | 6.65× | ||
| Q1 25 | 1.49× | 6.64× | ||
| Q4 24 | 3.93× | 6.36× | ||
| Q3 24 | 1.96× | 16.84× | ||
| Q2 24 | 2.14× | 15.87× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AEE
暂无分部数据
VTR
| Resident fees and services | $1.3B | 78% |
| Outpatient medical and research portfolio | $230.1M | 14% |
| Triple-net leased properties | $123.1M | 7% |
| Third-party capital management revenues | $4.4M | 0% |
